XML 64 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Variable Interest Entities (As Restated) - Revenue and Expenses of Delphax Included in the Company's Consolidated Statements of Operations (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues $ 38,522,990 $ 44,653,929 $ 69,016,243 $ 67,012,449
General and administrative 5,143,446 3,658,187 10,972,392 7,465,115
Research and development 239,922 750,882
Depreciation, amortization and impairment 353,672 192,504 2,343,273 371,121
37,501,251 39,149,278 75,067,986 62,556,898
Operating Loss 1,021,739 5,504,651 (6,051,743) 4,455,551
Non-operating Loss 433,075 (9,690) (854,823) (29,631)
Loss Before Income Taxes 1,454,814 5,494,960 (6,906,566) 4,425,920
Income Tax Expense (Benefit) 375,000 1,701,000 3,000 1,368,000
Net Loss $ 1,079,814 $ 3,793,960 (6,909,566) $ 3,057,920
Delphax [Member]        
Revenues     4,958,826  
Cost of sales     7,723,898  
General and administrative     1,704,852  
Research and development     750,882  
Depreciation, amortization and impairment     1,726,404  
    11,906,036  
Operating Loss     (6,947,210)  
Non-operating Loss     (45,147)  
Loss Before Income Taxes     (6,992,357)  
Income Tax Expense (Benefit)      
Net Loss     $ (6,992,357)